- Home
- ASYS vs GNTA Comparison
ASYS vs GNTA Comparison
Compare ASYS & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- GNTA
- Stock Information
- Founded
- ASYS 1981
- GNTA 2014
- Country
- ASYS United States
- GNTA Italy
- Employees
- ASYS N/A
- GNTA N/A
- Industry
- ASYS Industrial Machinery/Components
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASYS Technology
- GNTA Health Care
- Exchange
- ASYS Nasdaq
- GNTA Nasdaq
- Market Cap
- ASYS 59.4M
- GNTA 81.2M
- IPO Year
- ASYS N/A
- GNTA 2021
- Fundamental
- Price
- ASYS $4.48
- GNTA N/A
- Analyst Decision
- ASYS
- GNTA Strong Buy
- Analyst Count
- ASYS 0
- GNTA 1
- Target Price
- ASYS N/A
- GNTA $25.00
- AVG Volume (30 Days)
- ASYS 33.8K
- GNTA 29.4K
- Earning Date
- ASYS 08-06-2025
- GNTA 01-01-0001
- Dividend Yield
- ASYS N/A
- GNTA N/A
- EPS Growth
- ASYS N/A
- GNTA N/A
- EPS
- ASYS N/A
- GNTA N/A
- Revenue
- ASYS $90,826,000.00
- GNTA N/A
- Revenue This Year
- ASYS N/A
- GNTA N/A
- Revenue Next Year
- ASYS $28.60
- GNTA N/A
- P/E Ratio
- ASYS N/A
- GNTA N/A
- Revenue Growth
- ASYS N/A
- GNTA N/A
- 52 Week Low
- ASYS $3.20
- GNTA $2.74
- 52 Week High
- ASYS $6.96
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- ASYS 59.76
- GNTA 54.55
- Support Level
- ASYS $4.33
- GNTA $2.74
- Resistance Level
- ASYS $4.68
- GNTA $3.94
- Average True Range (ATR)
- ASYS 0.26
- GNTA 0.29
- MACD
- ASYS 0.02
- GNTA 0.08
- Stochastic Oscillator
- ASYS 70.51
- GNTA 88.33
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.